Showing results (331-340 of 355) with videos related to

Sort By:
Pageof 36
Journal of Medicinal Chemistry|August 6, 2004
Liver-selective glucocorticoid antagonists: a novel treatment for type 2 diabetesThomas W von Geldern, Noah Tu, Philip R Kym, et al.
Nature Communications|March 31, 2021
Peginterferon Lambda-1a for treatment of outpatients with uncomplicated COVID-19: a randomized placebo-controlled trialPrasanna Jagannathan, Jason R Andrews, Hector Bonilla, et al.
Journal of Medicinal Chemistry|April 14, 2006
2,4-diaminopyrimidine derivatives as potent growth hormone secretagogue receptor antagonistsMichael D Serby, Hongyu Zhao, Bruce G Szczepankiewicz, et al.
Synthetic and Systems Biotechnology|April 7, 2022
Comparative functional genomics identifies an iron-limited bottleneck in a Saccharomyces cerevisiae strain with a cytosolic-localized isobutanol pathwayFrancesca V Gambacorta, Ellen R Wagner, Tyler B Jacobson, et al.
The American Journal of Tropical Medicine and Hygiene|September 17, 2024
Gestational SARS-CoV-2 Infection in a Ugandan Birth Cohort: High Incidence, Mild Maternal Disease, and Evidence of Association with Transient Infant StuntingKaren B Jacobson, Katharina Röltgen, Brandon Lam, et al.
Cell Reports. Medicine|May 19, 2022
TNF-α+ CD4+ T cells dominate the SARS-CoV-2 specific T cell response in COVID-19 outpatients and are associated with durable antibodiesKattria van der Ploeg, Adam S Kirosingh, Diego A M Mori, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 24, 2005
Hepatic glucocorticoid receptor antagonism is sufficient to reduce elevated hepatic glucose output and improve glucose control in animal models of type 2 diabetesPeer B Jacobson, Thomas W von Geldern, Lars Ohman, et al.
Pageof 36